Chen, P.,
Yu, Y.,
Su, S.,
Du, Z.,
Cai, B.,
Sun, X.,
Chattipakorn, N.,
Samorodov, A.V.,
Pavlov, V.N.,
Tang, Q.,
Cho, W.-J.,
Liang, G. (2023) ) derivatives and evaluated their
anti-inflammatory
activities by measuring the release of cytokines
Yang, L.,
Luo, W.,
Zhang, Q,
Hong, S.,
Wang, Y.,
Samorodov, A.V.,
Chattipakorn, N.,
Pavlov, V.N.,
Liang, G. (2021) compounds were screened for their
anti-inflammatory activity in LPS-stimulated macrophages. PCR array, SPR
Ye, L.,
Chen, X.,
Wang, M.,
Jin, L.,
Zhuang, Z.,
Yang, D.,
Guan, X.,
Samorodov, A.V.,
Pavlov, V.N.,
Chattipakorn, N.,
Feng, J.,
Wang, Y.,
Luo, W.,
Liang, G. (2021) developed an
anti-inflammatory compound C66, which prevented
inflammatory diabetic complications via
Pashirova, T.N.,
Shaihutdinova, Z.M.,
Vandyukov, A.E.,
Lyubina, A.P.,
Amerhanova, S.K.,
Voloshina, A.D.,
Samorodov, A.V.,
Souto, E.B.,
Mironov, V.F.,
Mironov, V.F. (2022) and
anti-aggregation
activities were investigated. Established by tensiometry, conductometry, dynamic light
Qian, J.,
Zhuang, F.,
Chen, Y.,
Fan, X.,
Wang, J.,
Wang, Z.,
Wang, Y.,
Xu, M.,
Samorodov, A.V.,
Pavlov, V.N.,
Liang, G. (2022) of diabetic cardiomyopathy (DCM). This study aims to explore the non-
inflammatory mechanisms mediated by MD2